This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine

Hannu Rajaniemi, the co-founder and CEO of Helix Nanotechnologies, has spent the last year racing to come up with a mutation-resistant Covid-19 vaccine.

from Health and Science https://ift.tt/2PICJX6
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH